Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.
Morse
Jane H
JH
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
D000818:Animals; D055396:Bone Morphogenetic Protein 2; D052006:Bone Morphogenetic Protein Receptors, Type II; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000378:metabolism; D020372:Dexfenfluramine / Q000009:adverse effects; D005277:Fenfluramine / Q000009:adverse effects; D005776:Gaucher Disease / Q000150:complications; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012307:Risk Factors; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D016212:Transforming Growth Factor beta; D005277:Fenfluramine; D020372:Dexfenfluramine; D017346:Protein Serine-Threonine Kinases; C498218:BMPR2 protein, human; D052006:Bone Morphogenetic Protein Receptors, Type II